The latest price target for Verastem (NASDAQ:VSTM) was reported by Guggenheim on January 24, 2025. The analyst firm set a price target for $0.00 expecting VSTM to fall to within 12 months (a possible -100.00% downside). 19 analyst firms have reported ratings in the last year.

The latest analyst rating for Verastem (NASDAQ:VSTM) was provided by Guggenheim, and Verastem reiterated their buy rating.

The last upgrade for Verastem Inc happened on June 15, 2023 when Mizuho raised their price target to $36. Mizuho previously had a neutral for Verastem Inc.

There is no last downgrade for Verastem.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Verastem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Verastem was filed on January 24, 2025 so you should expect the next rating to be made available sometime around January 24, 2026.

While ratings are subjective and will change, the latest Verastem (VSTM) rating was a reiterated with a price target of $0.00 to $0.00. The current price Verastem (VSTM) is trading at is $6.30, which is out of the analyst’s predicted range.